Depressiogene Wirkungen von Betablockern - Ein medizinischer Mythos?

Dr. H. Frieling

Prof. Dr. S. Bleich

Literatur

• 1 Kornischka I, Cordes I, Angelink M W. 40 Jahre Betablocker in der Psychiatrie.  Fortschr Neurol Psychiat DOI: 10.1055/s-2006-944295.
• 2 Kohn R. Beta-blockers an important cause of depression: a medical myth without evidence.  Med Health R I. 2001;  84 92-95
• 3 Head A, Kendall M J, Ferner R, Eagles C. Acute effects of beta blockade and exercise on mood and anxiety.  Br J Sports Med. 1996;  30 238-242
• 4 Avorn J, Everitt D E, Weiss S. Increased antidepressant use in patients prescribed beta-blockers.  JAMA. 1986;  255 357-360
• 5 Thiessen B Q, Wallace S M, Blackburn J L, Wilson T W, Bergman U. Increased prescribing of antidepressants subsequent to beta-blocker therapy.  Arch Intern Med. 1990;  150 2286-2290
• 6 Lama P J. Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment.  Am J Ophthalmol. 2002;  134 749-760
• 7 Ko D T, Hebert P R, Coffey C S, Sedrakyan A, Curtis J P, Krumholz H M. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.  JAMA. 2002;  288 351-357
• 8 Bright R A, Everitt D E. Beta-blockers and depression. Evidence against an association.  JAMA. 1992;  267 1783-1787
• 9 Gerstman B B, Jolson H M, Bauer M, Cho P, Livingston J M, Platt R. The incidence of depression in new users of beta-blockers and selected antihypertensives.  J Clin Epidemiol. 1996;  49 809-815
• 10 Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis.  Epidemiology. 1996;  7 478-484
• 11 Steffensmeier J J, Ernst M E, Kelly M, Hartz A J. Do randomized controlled trials always trump case reports? A second look at propranolol and depression.  Pharmacotherapy. 2006;  26 162-167